Alp's with all due respect to you and the thread -
Post# of 30028
none of the 4 proposed milestones are revenue producing - none - period....yet we have salary increases and bonuses being paid on further dilution and poor milestone accomplishmnets previously in FY14
the Hare & Tortoise race is now squarely on LymPro - either generating RUO and LDT starter revenue, sales contracts, or a JV Agreement - with the later apparently not in the immediate cards -
it doesn't mean to say that a JV Agreement won't eventually happen, but why do it now, when it could be better to spin the Diagnostic's Div. off with LymPro unencumbered by a JV Agreement